Table 3: Factors associated with the prevalence of cannabinoid prescription for the management of chronic noncancer pain (CNCP).

Variable	Crude OR (95% CI)	Adjusted OR† (95% CI)
Sex, female (v. male)	0.96 (0.47–1.99)	–
Years of practice ≥ 21 (v. < 21)	1.26 (0.41– 3.81)	0.70 (0.17–2.84)
Other medical specialty (v. family physician/general practitioner)	0.17 (0.07–0.43)	0.14 (0.01– 1.71)
Work environment frequented in past year (yes v. no)
Hospital environment (excluding emergency department)	0.35 (0.16–0.75)	1.90 (0.42–8.51)
Family medicine group or unit	3.21 (1.48–6.96)	1.52 (0.40–5.86)
Emergency department	1.17 (0.49–2.78)	–
Private medical office	2.28 (0.86–6.00)	1.33 (0.29–6.15)
% of medical practice dedicated to seeing patients in past year, per 10% increase in proportion	1.01 (0.99–1.03)	–
No. of patients seen each week in medical practice, per 1-patient increase in weekly caseload	1.02 (1.01–1.02)	1.01 (0.99–1.02)
Perception of CNCP prevalence among clientele, per 10% increase in perceived prevalence	1.03 (1.01–1.05)	1.01 (0.98–1.04)
> 10% of CME activities about CNCP in past year (v. ≤ 10%)	1.04 (0.27–3.95)	–
≥ 1% of CME activities about cannabinoids in past year (v. 0%)	1.66 (0.48–5.67)	–
Level of comfort with prescribing cannabinoids for CNCP, per 1-point increase on comfort scale	2.04 (1.64–2.54)	1.25 (1.01–1.55)

Note: CI = confidence interval, CME = continuing medical education, OR = odds ratio.
*Unless stated otherwise.
†Adjusted for other factors in the table included in the multivariate model.